159 related articles for article (PubMed ID: 8485117)
1. Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288.
Konkle BA; Schick PK; He X; Liu RJ; Mazur EM
Arterioscler Thromb; 1993 May; 13(5):669-74. PubMed ID: 8485117
[TBL] [Abstract][Full Text] [Related]
2. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
[TBL] [Abstract][Full Text] [Related]
3. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line.
Hill SA; Shaughnessy SG; Joshua P; Ribau J; Austin RC; Podor TJ
Blood; 1996 Jun; 87(12):5061-73. PubMed ID: 8652819
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01.
Chuang JL; Schleef RR
J Cell Biochem; 2001; 82(2):277-89. PubMed ID: 11527153
[TBL] [Abstract][Full Text] [Related]
5. Detection of plasminogen activator inhibitor-1 (PAI-1) mRNA in human megakaryocytes by in situ hybridization.
Alessi MC; Chomiki N; Berthier R; Schweitzer A; Fossat C; Juhan-Vague I
Thromb Haemost; 1994 Dec; 72(6):931-6. PubMed ID: 7740466
[TBL] [Abstract][Full Text] [Related]
6. Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288-11 and normal human megakaryocytes.
Schick BP; Jacoby JA
J Cell Physiol; 1995 Oct; 165(1):96-106. PubMed ID: 7559813
[TBL] [Abstract][Full Text] [Related]
7. Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes, and human erythroleukemia cells.
Williams AG; Woolkalis MJ; Poncz M; Manning DR; Gewirtz AM; Brass LF
Blood; 1990 Aug; 76(4):721-30. PubMed ID: 2116927
[TBL] [Abstract][Full Text] [Related]
8. Cellular source of human platelet secretory phospholipase A2.
Emadi S; Mirshahi M; Elalamy I; Nicolas C; Vargaftig BB; Hatmi M
Br J Haematol; 1998 Feb; 100(2):365-73. PubMed ID: 9488628
[TBL] [Abstract][Full Text] [Related]
9. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
10. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate.
Schick BP; Thornton RD
Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770
[TBL] [Abstract][Full Text] [Related]
11. Promoter regulatory elements and DNase I-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells.
Schick BP; Petrushina I; Brodbeck KC; Castronuevo P
J Biol Chem; 2001 Jul; 276(27):24726-35. PubMed ID: 11333275
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.
Hashizume S; Akaike M; Azuma H; Ishikawa K; Yoshida S; Sumitomo-Ueda Y; Yagi S; Ikeda Y; Iwase T; Aihara K; Abe M; Sata M; Matsumoto T
J Atheroscler Thromb; 2011; 18(2):138-47. PubMed ID: 21060209
[TBL] [Abstract][Full Text] [Related]
13. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells.
Arts J; Grimbergen J; Toet K; Kooistra T
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):39-46. PubMed ID: 9888864
[TBL] [Abstract][Full Text] [Related]
14. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells.
Bosma PJ; Kooistra T
J Biol Chem; 1991 Sep; 266(27):17845-9. PubMed ID: 1655729
[TBL] [Abstract][Full Text] [Related]
15. Post-transcriptional regulation of plasminogen activator inhibitor type-1 expression in human pleural mesothelial cells.
Shetty S; Velusamy T; Shetty RS; Marudamuthu AS; Shetty SK; Florova G; Tucker T; Koenig K; Shetty P; Bhandary YP; Idell S
Am J Respir Cell Mol Biol; 2010 Sep; 43(3):358-67. PubMed ID: 19855086
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
Lund LR; Eriksen J; Ralfkiaer E; Rømer J
J Invest Dermatol; 1996 Apr; 106(4):622-30. PubMed ID: 8617995
[TBL] [Abstract][Full Text] [Related]
17. Meta-iodobenzylguanidine uptake in platelets, megakaryoblastic leukaemia cell lines MKPL-1 and CHRF-28-11 and erythroleukaemic cell line HEL.
Tytgat GA; Voûte PA; Takeuchi S; Miyoshi I; Rutgers M
Eur J Cancer; 1995; 31A(4):603-6. PubMed ID: 7576978
[TBL] [Abstract][Full Text] [Related]
18. Identification of Gz alpha as a pertussis toxin-insensitive G protein in human platelets and megakaryocytes.
Gagnon AW; Manning DR; Catani L; Gewirtz A; Poncz M; Brass LF
Blood; 1991 Sep; 78(5):1247-53. PubMed ID: 1908722
[TBL] [Abstract][Full Text] [Related]
19. Platelets synthesize large amounts of active plasminogen activator inhibitor 1.
Brogren H; Karlsson L; Andersson M; Wang L; Erlinge D; Jern S
Blood; 2004 Dec; 104(13):3943-8. PubMed ID: 15315974
[TBL] [Abstract][Full Text] [Related]
20. Induction of the c-ski proto-oncogene by phorbol ester correlates with induction of megakaryocyte differentiation.
Namciu S; Lieberman MA; Stavnezer E
Oncogene; 1994 May; 9(5):1407-16. PubMed ID: 8152801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
